Torthaí cuardaigh - Ehsan Parvaresh Rizi
- 1 - 3 toradh as 3 á dtaispeáint
-
1
A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men de réir Ehsan Parvaresh Rizi, Tze Ping Loh, Sonia Baig, Vanna Chhay, Shiqi Huang, Jonathan Caleb Quek, E Shyong Tai, Sue‐Anne Toh, Chin Meng Khoo
Foilsithe / Cruthaithe 2018Artigo -
2
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction de réir Stefan James, David Erlinge, Robert F. Storey, Darren K. McGuire, Mark de Belder, Ida Björkgren, Peter A. Johansson, Anna Maria Langkilde, Wilhelm Ridderstråle, Ehsan Parvaresh Rizi, John Deanfield, Jonas Oldgren
Foilsithe / Cruthaithe 2023Artigo -
3
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure de réir Stefan James, David Erlinge, Robert F. Storey, Darren K. McGuire, Mark de Belder, Niclas Eriksson, Kasper Andersen, David Austin, Gabriel Arefalk, David Carrick, Robin Hofmann, Stephen P. Hoole, Daniel A. Jones, Kelvin Lee, Hans Tygesen, Peter A. Johansson, Anna Maria Langkilde, Wilhelm Ridderstråle, Ehsan Parvaresh Rizi, John Deanfield, Jonas Oldgren
Foilsithe / Cruthaithe 2023Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Diabetes mellitus
Endocrinology
Internal medicine
Medicine
Alternative medicine
Cardiology
Dapagliflozin
Heart failure
Myocardial infarction
Pathology
Placebo
Type 2 diabetes
Appetite
Atrial fibrillation
Clinical trial
Confidence interval
Ghrelin
Glucagon-like peptide-1
Hazard ratio
Hormone
Insulin
Meal
Neuropeptide
Neuropeptide Y receptor
Peptide YY
Physical therapy
Postprandial
Randomization
Randomized controlled trial
Receptor